Comparing low-dose buccal buprenorphine to standard opioids for pain relief and abuse potential
Official title: Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
Run by Vanderbilt University Medical Center · NCT05988710 · Data updated 2026-11-12
This study is testing if a low-dose form of buprenorphine can relieve pain and has less potential for abuse compared to the standard opioid oxycodone, using healthy volunteers.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Status | Recruiting |
| Started | October 19, 2023 |
| Main results expected | January 2028 |
| Study ends | February 2028 |
| Registry record updated | January 12, 2026 |
| Trial ID | NCT05988710 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18-65 who have not used opioids in the past three months.
✕Probably not a fit
Patients with chronic pain, current or prior substance use disorders, or certain medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the abuse potential and analgesic effects of low-dose buccal buprenorphine compared to a commonly used opioid, oxycodone, in a controlled setting. It will involve 60 healthy participants who will undergo a within-subjects crossover design, receiving different doses of buprenorphine, placebo, and oxycodone across multiple sessions. Participants will be assessed for pain responsiveness and drug liking metrics to determine the relative safety and efficacy of buprenorphine as an alternative to traditional opioids.
Why it matters
Potential benefit: If successful, this study could provide a safer alternative to traditional opioids for pain management with a lower risk of abuse.
How similar studies have gone: Other studies have explored the safety and efficacy of buprenorphine, but this specific approach comparing low-dose buccal buprenorphine to oxycodone is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Intact cognitive status and ability to provide informed consent * Ability to read and write in English sufficiently to understand and complete study questionnaires * Age 18-65 * Opioid-naive status (defined as no use of full mu-opioid receptor (MOR) agonist, partial MOR agonist, or mixed agonist/antagonist medications for the prior 3 months by patient report Exclusion Criteria: * Liver/kidney disease * Chronic pain * Current/prior substance use disorder * Pregnancy (to avoid fetal drug exposure, with pregnancy tests conducted to confirm eligibility) * Seizure disorder * Certain psychiatric conditions (severe depression, bipolar disorder, psychotic disorders) * Recent use of medications that may interfere with study drug metabolism * Recent benzodiazepine or opioid use (confirmed via rapid urine screening prior to each lab session) * The presence of any medical conditions felt by the study physician to render participant unsafe * Prior allergic reaction or intolerance to oxycodone, buprenorphine, or their analogs (explicitly including moderate-to-severe nausea or vomiting with prior opioids) * Recent use of marijuana, delta-8 THC, CBD, and similar products * Recent use of kratom * Severe asthma * Long QT syndrome * Parkinson disease * Weight \<60 kg
Where it's running
-
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting
Study contacts
- Principal investigator: Daniel Larach, MD, MSTR, MA — Vanderbilt University Medical Center
- Study coordinator: Daniel Larach, MD, MSTR, MA
- Email: daniel.larach@vumc.org
- Phone: 615-322-6033
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
-
Esmolol vs Dexmedetomidine for opioid-sparing in laparoscopic gynecologic surgery
This study tests whether low-dose esmolol or dexmedetomidine, given during surgery, reduces opioid use and improves pain control after laparoscopic hysterectomy compared with placebo.
-
Three nerve blocks for knee replacement: which one works best
This trial tests three different nerve blocks used during knee replacement to see which provides the best pain relief for patients after surgery.
-
Rectointercostal plane block to reduce pain after laparoscopic gallbladder removal
This study tests whether giving a rectointercostal block during laparoscopic cholecystectomy can lower postoperative pain for patients without changing general anesthesia.
-
STIL block versus RIB with sub-serratus plane block for pain relief after pediatric chest surgery
This study tests whether the STIL plane block provides comparable or better pain relief than the combination of RIB and sub-serratus plane block in children after thoracotomy.
-
SPSIP Block to Help Pain After Breast Reduction Surgery
A randomized trial tests whether adding an ultrasound-guided SPSIP block can lower opioid use in the first 24 hours after bilateral breast reduction surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.